Michael E. Cahr

Michael E. Cahr is a declared insider at 5 companies; the most frequent names are Pacifichealth Laboratories Inc, Metropolitan Health Networks Inc and Lifecell Corp. We count 40 filings; the first trade dates from 23 February 2006 and the latest from 21 December 2012.

In open-market terms, that means 7 purchases worth €148k on one side and 11 sales worth €2.2M on the other. On balance, insiders were net sellers of €2.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 16 share grants and 4 option exercises.

Half of the purchases are above €12k and half below.

On 26 December 2012 came the latest disclosure, a transaction for €4.9M in Metropolitan Health Networks Inc. The latest purchase dates back some time: it was published 5,642 days ago, on 13 May 2011. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.